Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Teaching Rounds | 9 | 2024 | 276 | 3.980 |
Why?
|
HIV Infections | 32 | 2024 | 17342 | 0.830 |
Why?
|
Primary Health Care | 13 | 2021 | 4677 | 0.800 |
Why?
|
Diverticulitis | 1 | 2023 | 185 | 0.710 |
Why?
|
Practice Guidelines as Topic | 10 | 2021 | 7390 | 0.700 |
Why?
|
Acquired Immunodeficiency Syndrome | 7 | 2024 | 2197 | 0.640 |
Why?
|
Prostatic Hyperplasia | 1 | 2023 | 521 | 0.640 |
Why?
|
Anti-HIV Agents | 7 | 2024 | 4524 | 0.550 |
Why?
|
Gallstones | 1 | 2019 | 284 | 0.530 |
Why?
|
Hypogonadism | 1 | 2021 | 798 | 0.490 |
Why?
|
CD4 Lymphocyte Count | 11 | 2019 | 2567 | 0.470 |
Why?
|
Cytomegalovirus Retinitis | 1 | 2013 | 56 | 0.440 |
Why?
|
Substance Abuse, Intravenous | 7 | 2013 | 529 | 0.440 |
Why?
|
AIDS-Related Opportunistic Infections | 3 | 2013 | 662 | 0.440 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2022 | 1081 | 0.430 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 2 | 2011 | 138 | 0.420 |
Why?
|
Alcoholism | 8 | 2013 | 1972 | 0.390 |
Why?
|
Pancreatitis | 1 | 2019 | 1097 | 0.390 |
Why?
|
Bone Diseases | 1 | 2015 | 418 | 0.380 |
Why?
|
Internal Medicine | 3 | 2021 | 1051 | 0.370 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2021 | 1553 | 0.360 |
Why?
|
Testosterone | 1 | 2021 | 2472 | 0.350 |
Why?
|
Mass Screening | 4 | 2022 | 5425 | 0.350 |
Why?
|
Program Development | 1 | 2016 | 1293 | 0.350 |
Why?
|
Lipectomy | 1 | 2011 | 113 | 0.340 |
Why?
|
Physical Examination | 1 | 2016 | 1254 | 0.340 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2022 | 2020 | 0.330 |
Why?
|
Cytomegalovirus | 1 | 2013 | 748 | 0.330 |
Why?
|
Decision Making | 2 | 2021 | 3919 | 0.320 |
Why?
|
Aortic Valve Stenosis | 1 | 2021 | 2003 | 0.310 |
Why?
|
Disease Management | 1 | 2019 | 2506 | 0.310 |
Why?
|
Mental Health Services | 1 | 2020 | 1717 | 0.300 |
Why?
|
Sinusitis | 1 | 2017 | 991 | 0.290 |
Why?
|
Genetic Testing | 1 | 2020 | 3533 | 0.290 |
Why?
|
Drug Prescriptions | 1 | 2017 | 1669 | 0.290 |
Why?
|
Vitamin D Deficiency | 1 | 2016 | 1388 | 0.280 |
Why?
|
Guideline Adherence | 2 | 2016 | 2218 | 0.260 |
Why?
|
Patient Compliance | 5 | 2011 | 2688 | 0.260 |
Why?
|
Hepatitis C | 6 | 2013 | 1580 | 0.250 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 2373 | 0.250 |
Why?
|
Internship and Residency | 4 | 2021 | 5878 | 0.240 |
Why?
|
Memory Disorders | 1 | 2012 | 1197 | 0.240 |
Why?
|
Counseling | 1 | 2011 | 1538 | 0.220 |
Why?
|
Anti-Bacterial Agents | 3 | 2023 | 7403 | 0.220 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2023 | 174 | 0.210 |
Why?
|
Blood Pressure | 1 | 2018 | 8473 | 0.210 |
Why?
|
Attitude to Health | 2 | 2011 | 2025 | 0.210 |
Why?
|
Anti-Retroviral Agents | 5 | 2024 | 1783 | 0.200 |
Why?
|
Humans | 58 | 2024 | 760740 | 0.200 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2023 | 112 | 0.190 |
Why?
|
Alcohol Drinking | 6 | 2013 | 4028 | 0.180 |
Why?
|
Oxidoreductases | 1 | 2023 | 412 | 0.180 |
Why?
|
Vietnam | 3 | 2019 | 406 | 0.170 |
Why?
|
Aspartate Aminotransferases | 2 | 2019 | 414 | 0.170 |
Why?
|
Sex Reassignment Procedures | 1 | 2020 | 70 | 0.160 |
Why?
|
Outpatient Clinics, Hospital | 4 | 1995 | 393 | 0.160 |
Why?
|
Vaginal Smears | 1 | 2022 | 499 | 0.160 |
Why?
|
Male | 36 | 2023 | 360402 | 0.160 |
Why?
|
Alanine Transaminase | 2 | 2019 | 601 | 0.160 |
Why?
|
Hypertension | 1 | 2018 | 8532 | 0.150 |
Why?
|
Adult | 28 | 2022 | 220995 | 0.150 |
Why?
|
Hepatitis C, Chronic | 1 | 2006 | 1018 | 0.150 |
Why?
|
Cognition Disorders | 1 | 2012 | 3979 | 0.150 |
Why?
|
Israel | 1 | 2019 | 716 | 0.140 |
Why?
|
Acute Disease | 2 | 2019 | 7236 | 0.140 |
Why?
|
Referral and Consultation | 2 | 2020 | 3599 | 0.140 |
Why?
|
Gender Identity | 1 | 2023 | 765 | 0.140 |
Why?
|
Cholecystectomy | 1 | 2019 | 406 | 0.140 |
Why?
|
Genetic Counseling | 1 | 2020 | 627 | 0.140 |
Why?
|
HIV | 2 | 2019 | 1580 | 0.130 |
Why?
|
Middle Aged | 19 | 2021 | 220603 | 0.130 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2019 | 507 | 0.130 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2016 | 131 | 0.130 |
Why?
|
Peer Review, Health Care | 1 | 2016 | 73 | 0.130 |
Why?
|
Recurrence | 2 | 2019 | 8426 | 0.120 |
Why?
|
Female | 31 | 2023 | 392203 | 0.120 |
Why?
|
Colonoscopy | 1 | 2023 | 1397 | 0.120 |
Why?
|
Fluid Therapy | 1 | 2019 | 577 | 0.120 |
Why?
|
Androstadienes | 1 | 2016 | 348 | 0.120 |
Why?
|
Reminder Systems | 1 | 2018 | 386 | 0.120 |
Why?
|
Elasticity Imaging Techniques | 1 | 2019 | 391 | 0.120 |
Why?
|
Risk Assessment | 6 | 2016 | 23974 | 0.120 |
Why?
|
United States | 7 | 2024 | 72292 | 0.110 |
Why?
|
Liver | 2 | 2019 | 7512 | 0.110 |
Why?
|
Self-Assessment | 1 | 2016 | 399 | 0.110 |
Why?
|
Public Sector | 1 | 2015 | 264 | 0.110 |
Why?
|
Depression | 5 | 2012 | 8132 | 0.110 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 15498 | 0.110 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13635 | 0.110 |
Why?
|
Thromboembolism | 1 | 2020 | 991 | 0.110 |
Why?
|
Viral Load | 3 | 2019 | 3325 | 0.110 |
Why?
|
Estrogens | 1 | 2020 | 1521 | 0.110 |
Why?
|
Physician's Role | 1 | 2020 | 917 | 0.110 |
Why?
|
Drug Therapy, Combination | 1 | 2023 | 6305 | 0.100 |
Why?
|
Enteral Nutrition | 1 | 2019 | 794 | 0.100 |
Why?
|
Capacity Building | 1 | 2015 | 259 | 0.100 |
Why?
|
Aromatase Inhibitors | 1 | 2016 | 513 | 0.100 |
Why?
|
Risk Reduction Behavior | 2 | 2016 | 1110 | 0.100 |
Why?
|
Tamoxifen | 1 | 2016 | 965 | 0.100 |
Why?
|
Patient Preference | 1 | 2019 | 925 | 0.090 |
Why?
|
Chronic Disease | 3 | 2023 | 9310 | 0.090 |
Why?
|
Virus Diseases | 1 | 2017 | 718 | 0.090 |
Why?
|
Alzheimer Disease | 1 | 2012 | 8603 | 0.090 |
Why?
|
Medical Staff, Hospital | 1 | 1994 | 601 | 0.090 |
Why?
|
Aftercare | 1 | 2016 | 913 | 0.090 |
Why?
|
Risk Factors | 7 | 2020 | 74128 | 0.080 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3680 | 0.080 |
Why?
|
Clinical Laboratory Techniques | 1 | 1994 | 745 | 0.080 |
Why?
|
Breast Neoplasms | 1 | 2016 | 20988 | 0.080 |
Why?
|
Alcohol-Related Disorders | 2 | 2008 | 238 | 0.080 |
Why?
|
Antihypertensive Agents | 1 | 2018 | 2018 | 0.080 |
Why?
|
Bacterial Infections | 1 | 2017 | 1389 | 0.080 |
Why?
|
Echocardiography | 1 | 2021 | 4987 | 0.080 |
Why?
|
Weight Loss | 1 | 2019 | 2682 | 0.070 |
Why?
|
Triage | 1 | 1994 | 984 | 0.070 |
Why?
|
Immunoassay | 1 | 2011 | 744 | 0.070 |
Why?
|
Postmenopause | 1 | 2016 | 2511 | 0.070 |
Why?
|
Biopsy | 1 | 2019 | 6763 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3196 | 0.070 |
Why?
|
Longevity | 1 | 2015 | 1064 | 0.070 |
Why?
|
Aged | 8 | 2023 | 169092 | 0.070 |
Why?
|
Chi-Square Distribution | 3 | 2006 | 3410 | 0.070 |
Why?
|
Treatment Outcome | 6 | 2023 | 64572 | 0.070 |
Why?
|
Vision Disorders | 1 | 2013 | 1088 | 0.070 |
Why?
|
Body Image | 1 | 2011 | 639 | 0.070 |
Why?
|
Prevalence | 3 | 2013 | 15702 | 0.070 |
Why?
|
Neoplasms | 1 | 2015 | 22131 | 0.070 |
Why?
|
Clinical Competence | 3 | 2016 | 4790 | 0.060 |
Why?
|
Prospective Studies | 11 | 2019 | 54364 | 0.060 |
Why?
|
Lymphatic Diseases | 1 | 1987 | 320 | 0.060 |
Why?
|
Ambulatory Care | 1 | 2016 | 2768 | 0.060 |
Why?
|
Linear Models | 3 | 2013 | 5866 | 0.060 |
Why?
|
Guidelines as Topic | 1 | 2011 | 1386 | 0.060 |
Why?
|
Informed Consent | 1 | 2011 | 1007 | 0.060 |
Why?
|
Diagnosis, Differential | 4 | 2017 | 12966 | 0.060 |
Why?
|
Cross-Sectional Studies | 6 | 2013 | 26065 | 0.060 |
Why?
|
Visual Acuity | 1 | 2013 | 2676 | 0.060 |
Why?
|
Dietary Supplements | 1 | 2016 | 3412 | 0.060 |
Why?
|
Physicians | 1 | 2021 | 4583 | 0.050 |
Why?
|
Curriculum | 1 | 2016 | 3739 | 0.050 |
Why?
|
Vitamin D | 1 | 2016 | 3301 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2023 | 26183 | 0.050 |
Why?
|
Boston | 7 | 2016 | 9313 | 0.050 |
Why?
|
Liver Cirrhosis | 1 | 2013 | 1927 | 0.050 |
Why?
|
Quality Improvement | 2 | 2015 | 3801 | 0.050 |
Why?
|
Health Care Costs | 1 | 2016 | 3238 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 3798 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2011 | 5493 | 0.050 |
Why?
|
Zidovudine | 3 | 1992 | 624 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2013 | 12043 | 0.050 |
Why?
|
Quality Assurance, Health Care | 1 | 2012 | 2164 | 0.050 |
Why?
|
Academic Medical Centers | 1 | 2012 | 2756 | 0.050 |
Why?
|
Time Factors | 5 | 2016 | 39908 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2016 | 4325 | 0.050 |
Why?
|
Sexual Behavior | 1 | 2011 | 2187 | 0.050 |
Why?
|
Depressive Disorder | 3 | 2009 | 3735 | 0.050 |
Why?
|
Substance-Related Disorders | 2 | 2008 | 4416 | 0.050 |
Why?
|
Hospitals, Municipal | 3 | 1995 | 19 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 1994 | 3882 | 0.050 |
Why?
|
Health Behavior | 2 | 2007 | 2643 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2018 | 4810 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20556 | 0.040 |
Why?
|
HIV-1 | 3 | 2007 | 6858 | 0.040 |
Why?
|
Risk | 1 | 2011 | 9603 | 0.040 |
Why?
|
Comorbidity | 3 | 2012 | 10507 | 0.040 |
Why?
|
Young Adult | 3 | 2022 | 59191 | 0.040 |
Why?
|
Blotting, Western | 1 | 2006 | 5034 | 0.040 |
Why?
|
Physician-Patient Relations | 1 | 2011 | 3239 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15250 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2015 | 5334 | 0.040 |
Why?
|
HIV Protease Inhibitors | 1 | 1999 | 432 | 0.030 |
Why?
|
Antiretroviral Therapy, Highly Active | 3 | 2012 | 1894 | 0.030 |
Why?
|
Cohort Studies | 8 | 2013 | 41464 | 0.030 |
Why?
|
Lithium | 1 | 1979 | 596 | 0.030 |
Why?
|
Analysis of Variance | 2 | 1994 | 6223 | 0.030 |
Why?
|
Cocaine-Related Disorders | 2 | 2009 | 461 | 0.030 |
Why?
|
Staphylococcal Infections | 1 | 1984 | 1406 | 0.030 |
Why?
|
Medical Assistance | 1 | 2015 | 108 | 0.030 |
Why?
|
Complementary Therapies | 1 | 1998 | 486 | 0.030 |
Why?
|
Risk-Taking | 2 | 2013 | 1038 | 0.030 |
Why?
|
RNA, Viral | 3 | 2007 | 2838 | 0.030 |
Why?
|
Fees, Medical | 1 | 1994 | 111 | 0.030 |
Why?
|
Nuclear Family | 1 | 2015 | 311 | 0.030 |
Why?
|
Matched-Pair Analysis | 1 | 1994 | 284 | 0.030 |
Why?
|
Appointments and Schedules | 1 | 2018 | 442 | 0.030 |
Why?
|
Electrolytes | 1 | 1994 | 274 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 1990 | 7995 | 0.030 |
Why?
|
Massachusetts | 1 | 2006 | 8835 | 0.030 |
Why?
|
Liver Function Tests | 1 | 1994 | 524 | 0.030 |
Why?
|
Longitudinal Studies | 4 | 2013 | 14599 | 0.030 |
Why?
|
Information Systems | 1 | 1995 | 396 | 0.030 |
Why?
|
Sex Factors | 1 | 2006 | 10549 | 0.030 |
Why?
|
Inflammation | 1 | 2012 | 10759 | 0.020 |
Why?
|
AIDS-Related Complex | 2 | 1992 | 107 | 0.020 |
Why?
|
Insurance, Health, Reimbursement | 1 | 1994 | 385 | 0.020 |
Why?
|
Pharmacy Service, Hospital | 1 | 2012 | 134 | 0.020 |
Why?
|
Sexual Partners | 1 | 2015 | 800 | 0.020 |
Why?
|
Health Services Research | 1 | 2018 | 1808 | 0.020 |
Why?
|
Prognosis | 2 | 2006 | 29601 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2015 | 58919 | 0.020 |
Why?
|
Sepsis | 1 | 1984 | 2585 | 0.020 |
Why?
|
Age Factors | 1 | 2006 | 18381 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 1995 | 1191 | 0.020 |
Why?
|
Regression Analysis | 2 | 2009 | 6339 | 0.020 |
Why?
|
AIDS Serodiagnosis | 1 | 2009 | 219 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 1994 | 1302 | 0.020 |
Why?
|
Arthralgia | 1 | 2012 | 461 | 0.020 |
Why?
|
Program Evaluation | 1 | 2016 | 2486 | 0.020 |
Why?
|
Heroin Dependence | 1 | 2008 | 172 | 0.020 |
Why?
|
Syphilis Serodiagnosis | 1 | 1987 | 37 | 0.020 |
Why?
|
Leukemia, Lymphoid | 1 | 1987 | 310 | 0.020 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2007 | 166 | 0.020 |
Why?
|
Software Design | 1 | 1987 | 171 | 0.020 |
Why?
|
Cell Death | 1 | 1992 | 1677 | 0.020 |
Why?
|
Infectious Mononucleosis | 1 | 1987 | 133 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 1992 | 1550 | 0.020 |
Why?
|
Health Expenditures | 1 | 1998 | 2363 | 0.020 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2012 | 709 | 0.020 |
Why?
|
Antiviral Agents | 2 | 2006 | 3037 | 0.020 |
Why?
|
Logistic Models | 2 | 2016 | 13248 | 0.020 |
Why?
|
Anthropometry | 1 | 2009 | 1338 | 0.010 |
Why?
|
Headache | 1 | 2012 | 1255 | 0.010 |
Why?
|
Sample Size | 1 | 2007 | 838 | 0.010 |
Why?
|
Connective Tissue Diseases | 1 | 1987 | 285 | 0.010 |
Why?
|
Ambulatory Care Facilities | 1 | 1990 | 934 | 0.010 |
Why?
|
Awareness | 1 | 2007 | 649 | 0.010 |
Why?
|
Population Surveillance | 1 | 2013 | 2597 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2012 | 2419 | 0.010 |
Why?
|
Interferon Type I | 1 | 2006 | 557 | 0.010 |
Why?
|
Odds Ratio | 2 | 2009 | 9644 | 0.010 |
Why?
|
Bipolar Disorder | 1 | 1979 | 5091 | 0.010 |
Why?
|
Quality Indicators, Health Care | 1 | 2012 | 1790 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2012 | 39062 | 0.010 |
Why?
|
Health Personnel | 1 | 2015 | 3333 | 0.010 |
Why?
|
Schizophrenia | 1 | 1979 | 6929 | 0.010 |
Why?
|
Disease Progression | 2 | 2007 | 13495 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2008 | 12448 | 0.010 |
Why?
|
Catheterization | 1 | 1984 | 1428 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2008 | 6016 | 0.010 |
Why?
|
Pneumonia, Pneumocystis | 1 | 1999 | 242 | 0.010 |
Why?
|
Lymphoma | 1 | 1987 | 1899 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 2001 | 753 | 0.010 |
Why?
|
Macrophages | 1 | 1992 | 5758 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6520 | 0.010 |
Why?
|
Medicare | 1 | 1994 | 6774 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 7963 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 1984 | 1457 | 0.010 |
Why?
|
Diagnostic Tests, Routine | 1 | 2001 | 786 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2018 | 80583 | 0.010 |
Why?
|
Telephone | 1 | 1998 | 626 | 0.010 |
Why?
|
Survival Analysis | 1 | 2008 | 10072 | 0.010 |
Why?
|
Cross Infection | 1 | 1984 | 1422 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1992 | 10175 | 0.010 |
Why?
|
Medical Records | 1 | 1998 | 1408 | 0.010 |
Why?
|
Homosexuality, Male | 1 | 2001 | 1333 | 0.010 |
Why?
|
Models, Statistical | 1 | 2007 | 5074 | 0.010 |
Why?
|
Hospital Information Systems | 1 | 1995 | 394 | 0.010 |
Why?
|
Models, Organizational | 1 | 1995 | 544 | 0.010 |
Why?
|
Community Health Centers | 1 | 1995 | 460 | 0.010 |
Why?
|
Syphilis, Latent | 1 | 1991 | 2 | 0.010 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 1991 | 76 | 0.010 |
Why?
|
AIDS Dementia Complex | 1 | 1991 | 153 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2001 | 2896 | 0.000 |
Why?
|
Health Services Needs and Demand | 1 | 1995 | 1400 | 0.000 |
Why?
|
Algorithms | 1 | 1987 | 14024 | 0.000 |
Why?
|
HIV Seropositivity | 1 | 1991 | 959 | 0.000 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1991 | 831 | 0.000 |
Why?
|
Occupational Diseases | 1 | 1991 | 1490 | 0.000 |
Why?
|
Hospitalization | 1 | 2001 | 10708 | 0.000 |
Why?
|
Occupational Exposure | 1 | 1991 | 1813 | 0.000 |
Why?
|